Back to Duquesne Family Office LLC Duquesne Family Office LLC

RYTM

2 quarters

Position history for Duquesne Family Office LLCDuquesne Family Office LLC's holdings in Rhythm Pharmaceuticals, Inc.

Yes. Duquesne Family Office holds 269,900 shares of RYTM (Rhythm Pharmaceuticals), worth $25.7M, as of its Q3 2026 13F filing. It increased the position by 66,282 shares (+32.6%) from Q2 2026. Duquesne Family Office has held RYTM since Q2 2026, across 2 quarterly 13F filings. RYTM is 0.6% of Duquesne Family Office's reported 13F portfolio.

Current Value

$25.7M

Current Shares

269,900

Total Value Change

+$3.1M

Total Shares Change

+66,282

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
269,900
+32.5%
$25.7M0.6%$95.22
52
2026-Q2
New
203,618
-
$22.6M0.4%$111.03
47

Other major holders of RYTM: RA Capital Management, L.P., BlackRock, Inc., Vanguard Group Inc.

Optional analytics helps us improve. How it’s used